Abstract
PB1189 Concentrations of Direct Oral Anticoagulants Acting as FXa Inhibitors Could not be Accurately Determined in Patients Treated with Therapeutic Doses of Low Molecular Heparin as Bridging Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have